LNSR LENSAR, Inc.

Nasdaq lensar.com


$ 11.83 $ -0.37 (-3.09 %)    

Wednesday, 15-Oct-2025 16:15:55 EDT
QQQ $ 602.61 $ 4.22 (0.71 %)
DIA $ 463.04 $ 0.00 (0 %)
SPY $ 665.11 $ 2.94 (0.44 %)
TLT $ 90.76 $ -0.20 (-0.22 %)
GLD $ 387.41 $ 6.60 (1.73 %)
$ 11.61
$ 12.01
$ 10.00 x 10
$ 12.48 x 50
$ 11.61 - $ 12.02
$ 5.25 - $ 17.31
49,065
na
138.56M
$ 0.20
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-27-2025 01-01-1970 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-04-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-16-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-08-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 03-03-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 03-12-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lensar-q2-eps-015-compared-with-079-yoy-sales-13935m-miss-16550m-estimate

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.02) by 6...

 alcon-secures-first-fda-approval-since-novartis-spin-off-in-2019

FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural te...

 lensar-q1-eps-232-misses-021-estimate-sales-1416m-beat-1340m-estimate

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(2.32) per share which missed the analyst consensus estimate of $(0.21) by 1...

 alcon-eyes-surgical-edge-with-lensar-buyout-details

Alcon is set to acquire LENSAR Inc. in a $356 million deal. This acquisition includes LENSAR's advanced cataract laser tech...

 lake-street-maintains-buy-on-lensar-raises-price-target-to-16

Lake Street analyst Frank Takkinen maintains LENSAR (NASDAQ:LNSR) with a Buy and raises the price target from $12 to $16.

 lensar-q4-eps-161-misses-018-estimate-sales-1673m-beat-1490m-estimate

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(1.61) per share which missed the analyst consensus estimate of $(0.18) by 7...

 lensar-q3-2024-gaap-eps-013-beats-027-estimate-sales-13539m-beat-11500m-estimate

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.27) by 51....

 lensar-q2-2024-adj-eps-046-misses-029-estimate-sales-12636m-beat-12150m-estimate

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.29) by 5...

 lensar-q1-2024-gaap-eps-019-beats-028-estimate-sales-10588m-beat-10550m-estimate

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.28) by 32....

 lake-street-initiates-coverage-on-lensar-with-buy-rating-announces-price-target-of-8

Lake Street initiates coverage on LENSAR (NASDAQ:LNSR) with a Buy rating and announces Price Target of $8.

 lensar-q4-eps-035-misses-022-estimate-sales-1211m-beat-1200m-estimate

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.22) by 5...

 earnings-scheduled-for-march-4-2024

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.

 earnings-preview-lensar
Earnings Preview: LENSAR
03/01/2024 15:02:11

 lensar-q3-eps-023-beats-034-estimate-sales-979m-miss-1020m-estimate

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.34) by 32....

 earnings-scheduled-for-november-9-2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

 lensars-earnings-outlook
LENSAR's Earnings Outlook
11/08/2023 17:01:49

 why-nanovibronix-shares-are-trading-higher-by-49-here-are-20-stocks-moving-premarket

Gainers AgileThought, Inc. (NASDAQ: AGIL) rose 96.5% to $0.3046 in pre-market trading after falling 17% on Tuesday.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION